We are live on ! Find out more
QNRX

Quoin Pharmaceuticals
QNRX

1 hedge funds and large institutions have $741K invested in Quoin Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% less capital invested

Capital invested by funds: $1.45M → $741K (-$705K)

50% less funds holding

Funds holding: 2 → 1 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$602K
2
UBS Group
UBS Group
Switzerland
-$11K

QNRX Hedge Fund Activity: Q3 2018 in Review

1 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q3 2018, worth a combined $741K — down 49% from $1.45M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of QNRX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Susquehanna International Group, exiting entirely with an estimated $602K sold.

  • 1 institutional investor held Quoin Pharmaceuticals (QNRX) as of Q3 2018, down from 2 in Q2 2018.
  • Funds reported $741K of Quoin Pharmaceuticals stock for Q3 2018, down 49% quarter-over-quarter.
  • 0 funds opened new Quoin Pharmaceuticals positions in Q3 2018 and 1 closed out, a net change of -1 holder.
  • The largest Quoin Pharmaceuticals seller in Q3 2018 was Susquehanna International Group, an estimated $602K sold.

Based on aggregated 13F filings for Q3 2018.